EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine by unknown
MEETING ABSTRACT Open Access
EHMTI-0394. Predictive parameters for the effect of
botulinum toxin infiltrations in chronic migraine
BA Bergmans1*, R Bruffaerts2, M Verhalle3, L Vanopdenbosch1, K Verhoeven1, A Van Dycke1, O Deryck1
From 4th European Headache and Migraine Trust International Congress: EHMTIC 2014
Copenhagen, Denmark. 18-21 September 2014
Introduction
Since the PREEMPT trials botulinum toxin infiltrations
have become mainstay treatments for chronic migraine.
Although not reimbursed in Belgium, botulinum toxin
infiltrations can be a viable option for refractory chronic
migraine patients in whom previous oral treatments
have failed.
Aims
We report on the effectiveness and side effects of
botulinum toxin infiltrations for chronic migraine.
We investigate which parameters influence the effect
of the treatment.
Methods
Patients meeting criteria for chronic migraine who had
failed conventional oral treatments for the condition were
proposed botulinum toxin infiltrations. After informed
consent, they were asked to keep detailed headache
calendars, documenting the number of headache days,
the number of migraine days, the intensity of the head-
aches/migraines and analgetic use. We compared these
parameters before treatment and after two cycles of botu-
linum toxin infiltrations. Statistical significance was calcu-
lated by means of a Wilcoxon signed rank test.
Results
In our preliminary cohort of 7 patients treated with
botulinum toxin no major adverse events were reported.
One patient reported a mild transient unilateral ptosis
that did not hamper vision.
On average we observed a reduction in headache days
from 26.6 days/month before treatment to 22.0 days/
month after treatment (p = 0.250). The number of
migraine days after 2 cycles was reduced on average from
15.6 to 8.2 migraine days/month (p = 0.016). The average
reduction of the number of days that painkillers were used
after 2 treatment cycles, was much less pronounced, from
9.1 to 7.6 days/month (p = 0.406).
Conclusions
In our experience, even though high doses of botulinum
toxin are used in chronic migraine, the treatment is safe.
In selected patients with refractory chronic migraine
botulinum toxin infiltrations can significantly improve
the headache control. We observed that there is a sub-
population of patients with a distinct and significant
effect of the infiltrations who will continue treatment
beyond 2 treatment cycles. Another subpopulation
seems to have little or no benefit from the infiltrations
and will discontinue treatment after 2 cycles.
We will investigate in a regression analysis in 20 patients
which patient characteristics influence the success of the
botulinum toxin treatments.
Authors’ details
1Neurology, AZ St-Jan Brugge-Oostende AV Campus Brugge, Brugge,
Belgium. 2Neurology Neurosciences, UZ Leuven Laboratory for Cognitive
Neurology University of Leuven, Leuven, Belgium. 3Neurology, AZ St-Jan
Brugge-Oostende AV Campus Henri Serruys, Oostende, Belgium.
Published: 18 September 2014
doi:10.1186/1129-2377-15-S1-M1
Cite this article as: Bergmans et al.: EHMTI-0394. Predictive parameters
for the effect of botulinum toxin infiltrations in chronic migraine. The
Journal of Headache and Pain 2014 15(Suppl 1):M1.
1Neurology, AZ St-Jan Brugge-Oostende AV Campus Brugge, Brugge,
Belgium
Full list of author information is available at the end of the article
Bergmans et al. The Journal of Headache and Pain 2014, 15(Suppl 1):M1
http://www.thejournalofheadacheandpain.com/content/15/S1/M1
© 2014 Bergmans et al; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
